B-
BiotechTV - News
Jefferies London 2026: Protagonist Therapeutics' CEO Dinesh Patel discusses the launch of ICOTYDE, and the company's pipeline, which is well funded now due to commercial success
0:00-11:22
He comments on the early days of JNJ's ICOTYDE launch, developing an optimized IL-17, the obesity space, and more.
Publisher
BiotechTV - News
Link
podcasters.spotify.com/pod/show/biotechtv4/episodes/Jefferies-London-2026-Protagonist-Therapeutics-CEO-Dinesh-Patel-discusses-the-launch-of-ICOTYDE--and-the-companys-pipeline--which-is-well-funded-now-due-to-commercial-success-e3shqbi
Published
November 17, 2026
Duration
11 min
Format
Podcast
Category
Issues ยท Science
Source
RSS feed
Host
BiotechTV
B-
BiotechTV - News
@biotechtvnews
#protagonisttherapeuticsceo #fundednowdue #commercialsuccess #lifesciences
